<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It is important to distinguish <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) from <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> related to <z:mp ids='MP_0001853'>carditis</z:mp> because these conditions have a different natural history, risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, and treatment </plain></SENT>
<SENT sid="1" pm="."><plain>However, the distinction between these entities is difficult both clinically and pathologically </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to evaluate and compare the immunostaining pattern of five mucin core <z:chebi fb="1" ids="15841">polypeptides</z:chebi> in BE to cases of <z:mp ids='MP_0001853'>carditis</z:mp> or <z:e sem="disease" ids="C0024959" disease_type="Disease or Syndrome" abbrv="">antritis</z:e> with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Routinely processed mucosal biopsies from 22 patients with intestinal-type BE, 24 patients with cardia <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (10 Helicobacter pylori positive), 17 patients with antral <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (<z:hpo ids='HP_0000001'>all</z:hpo> H. pylori positive), 20 control patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> antrum, and 22 control patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> cardia were immunostained with monoclonal antibodies against MUC1, MUC2, MUC3, MUC5AC, and MUC6 mucin core <z:chebi fb="1" ids="15841">polypeptides</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Staining was evaluated separately for goblet cells and non-goblet columnar cells and compared between <z:hpo ids='HP_0000001'>all</z:hpo> groups </plain></SENT>
<SENT sid="5" pm="."><plain>A significantly higher number of BE cases (P &lt; 0.05) showed goblet cell staining for MUC1 (55%) or MUC6 (32%) compared with patients with <z:mp ids='MP_0001853'>carditis</z:mp> with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (MUC1 14%, MUC6 7%) or <z:e sem="disease" ids="C0024959" disease_type="Disease or Syndrome" abbrv="">antritis</z:e> with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (MUC1 6%, MUC6 0%) </plain></SENT>
<SENT sid="6" pm="."><plain>BE also showed a higher frequency of MUC1 and MUC6 positivity in non-goblet columnar cells compared with <z:mp ids='MP_0001853'>carditis</z:mp> and <z:e sem="disease" ids="C0024959" disease_type="Disease or Syndrome" abbrv="">antritis</z:e> cases with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>Only cases of BE showed combined MUC1 and MUC6 staining (sensitivity 23%, specificity 100%) </plain></SENT>
<SENT sid="8" pm="."><plain>The sensitivity and specificity of MUC1 staining for BE are 55% and 96%, respectively, and for MUC6 staining 30% and 96%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>Interestingly, <z:mpath ids='MPATH_458'>normal</z:mpath> gastric cardia mucosa also showed a significantly higher prevalence of MUC2 and MUC3 expression in glandular epithelium (29% and 38%, respectively) compared with the antrum (0% for both markers) (P &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, MUC1 and MUC6 expression in BE is distinct from that of the cardia and antrum with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>; thus, immunophenotyping for these markers may have some value in a subset of patients in helping to separate BE from patients with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> of the cardia </plain></SENT>
<SENT sid="11" pm="."><plain>Columnar epithelium in the "<z:mpath ids='MPATH_458'>normal</z:mpath>" gastric cardia has a partially intestinalized phenotype and, as a result, may represent an early form of metaplastic epithelium </plain></SENT>
</text></document>